David R. Hathaway

ArgiNOx Pharmaceuticals, Inc. focused on the discovery and development of medicines to treat hospitalized patients. The company's initial area of research and development is directed at nitric oxide-mediated pathways. Arginox's lead compound, Tilarginine Acetate Injection, is in late-stage clinical evaluation for the treatment of cardiogenic shock. The company was incorporated on March 24, 2004 and was headquartered in Redwood City, CA.

HeartWare Pty. Ltd. develops and manufactures implantable circulatory assist devices. Its devices are used in treating patients with congestive heart failure. The company is headquartered in Sydney, Australia.

Presym, Inc. manufactured non-invasive medical devices. It provided research and development, commercialization of products. Its products included TrCG, Endotracheal Tube operating room device and ETrCG. The company was headquartered in Pleasanton, CA.

American College of Physicians, Inc. operates as a medical-specialty organization. It is a national organization of internists and physician specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and care of adults from health to complex illness. Its members include internists, internal medicine subspecialists, medical students, residents, and fellows. The company was founded in 1915 and is headquartered Philadelphia, PA.

American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC.

American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI.